Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

Peer M. Aries; Peter Lamprecht; Wolfgang L. Gross

Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

Peer M. Aries^*, Peter Lamprecht, Wolfgang L. Gross

^*Corresponding author for this work

Department of Rheumatology and Clinical Immunology

University of Kiel

11 Citations (Scopus)

Original language	English
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	173
Issue number	7
Pages (from-to)	815-816
Number of pages	2
ISSN	1073-449X
Publication status	Published - 01.04.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this

@article{be5c0dee17ca41ad8933ed4788d9296f,

title = "Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]",

author = "Aries, \{Peer M.\} and Peter Lamprecht and Gross, \{Wolfgang L.\}",

year = "2006",

month = apr,

day = "1",

language = "English",

volume = "173",

pages = "815--816",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

AU - Aries, Peer M.

AU - Lamprecht, Peter

AU - Gross, Wolfgang L.

PY - 2006/4/1

Y1 - 2006/4/1

UR - https://www.scopus.com/pages/publications/33645286185

M3 - Letters

C2 - 16556703

AN - SCOPUS:33645286185

SN - 1073-449X

VL - 173

SP - 815

EP - 816

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 7

ER -

Rituximab in refractory Wegener's granulomatosis: Favorable or not? [3]

UN SDGs

Research Areas and Centers

Other files and links

Cite this